The additive burden of iron deficiency in the cardiorenal-anaemia axis: Scope of a problem and its consequences

European Journal of Heart Failure

Volumn 16, Issue 6, 2014, Pages 655-662

  Klip, Ijsbrand T ^a   Jankowska, Ewa A ^b,c   Enjuanes, Cristina ^d   Voors, Adriaan A ^a   Banasiak, Waldemar ^c   Bruguera, Jordi ^d   Rozentryt, Piotr ^e   Polonski, Lech ^e   Van Veldhuisen, Dirk J ^a   Ponikowski, Piotr ^b,c   Comin Colet, Josep ^d   Van Der Meer, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c MILITARY HOSPITAL   (Poland)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Anaemia; Heart failure; Iron deficiency; Kidney disease

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; IRON DEFICIENCY ANEMIA; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; POLAND; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SPAIN; SURVIVAL RATE; BLOOD; CLINICAL TRIAL; FOLLOW UP; KIDNEY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SURVIVAL;

AGED; ANEMIA, IRON-DEFICIENCY; CARDIO-RENAL SYNDROME; COMORBIDITY; FEMALE; FERRITINS; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSFERRIN;

EID: 84901986431     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.84     Document Type: Article

References (34)

1. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P,. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008; 52: 818-827.
2. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG,. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113: 2713-2723. (Pubitemid 43947989)
3. Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB,. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2008; 51: 569-576.
4. van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA,. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 2013; 61: 1973-1981.
5. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM,. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006; 47: 1987-1996.
6. Anand IS, Chandrashekhar Y, Ferrari R, Poole-Wilson PA, Harris PC,. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993; 70: 357-362. (Pubitemid 23309546)
7. Silverberg DS, Wexler D, Blum M, Iaina A,. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol 2003; 60 (Suppl 1): S93-S102. (Pubitemid 36889544)
8. van der Meer P, van Veldhuisen DJ,. Anaemia and renal dysfunction in chronic heart failure. Heart 2009; 95: 1808-1812.
9. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM,. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006; 48: 1225-1227. (Pubitemid 44345150)
10. Toblli JE, Lombrana A, Duarte P, Di Gennaro F,. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007; 50: 1657-1665. (Pubitemid 47562670)
11. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P,. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008; 51: 103-112.
12. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448.
13. Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Merono O, Ribas N, Ruiz S, Gomez M, Verdu JM, Bruguera J,. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail 2013; 15: 1164-1172.
14. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, von Haehling S, Doehner W, Banasiak W, Polonski L, Filippatos G, Anker SD, Ponikowski P,. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 2011; 17: 899-906.
15. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA,. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013; 165: 575-582.e3.
16. Macdougall IC, Canaud B, de Francisco AL, Filippatos G, Ponikowski P, Silverberg D, van Veldhuisen DJ, Anker SD,. Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency. Eur J Heart Fail 2012; 14: 882-886.
17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P,. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
18. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
19. Beilby J, Olynyk J, Ching S, Prins A, Swanson N, Reed W, Harley H, Garcia-Webb P,. Transferrin index: an alternative method for calculating the iron saturation of transferrin. Clin Chem 1992; 38: 2078-2081.
20. Parikh A, Natarajan S, Lipsitz SR, Katz SD,. Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation. Circ Heart Fail 2011; 4: 599-606.
21. de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, Bhandari S, Clark AL, Cleland JG,. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol 2006; 98: 391-398. (Pubitemid 44062453)
22. Scrutinio D, Passantino A, Santoro D, Catanzaro R,. The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival. Eur J Heart Fail 2011; 13: 61-67.
23. Lu KJ, Kearney LG, Hare DL, Ord M, Toia D, Jones E, Burrell LM, Srivastava PM,. Cardiorenal anemia syndrome as a prognosticator for death in heart failure. Am J Cardiol 2013; 111: 1187-1191.
24. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA,. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 2011; 58: 1241-1251.
25. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI,. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006; 48: 2485-2489. (Pubitemid 44881220)
26. Weiss G, Goodnough LT,. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
27. Simcox JA, McClain DA,. Iron and diabetes risk. Cell Metab 2013; 17: 329-341.
28. van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC,. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol 2011; 8: 485-493.
29. Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J,. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond) 2005; 109: 277-286. (Pubitemid 41337132)
30. Filippatos G, Farmakis D, Colet JC, Dickstein K, Luscher TF, Willenheimer R, Parissis J, Gaudesius G, Mori C, von Eisenhart RB, Greenlaw N, Ford I, Ponikowski P, Anker SD,. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail 2013; 15: 1267-1276.
31. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M,. STROBE initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007; 147: W163-W194. (Pubitemid 351664503)
32. Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M, Rashid M, Kang S, Weissert S, Coats CJ, Richards T, Thomas M, Woldman S, Okonko DO,. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol 2013; 168: 1997-2002.
33. KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530.
34. Locatelli F, Barany P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Horl W, London G, Vanholder R, Van Biesen W, ERA-EDTA ERBP Advisory Board. Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant 2013; 28: 1346-1359.